Table 3.
Predictors of all-cause mortality at 1-year follow up.
| Multivariable Cox regression analysis | |||
|---|---|---|---|
| Adjusted hazard ratio | 95% confidence interval | p-value | |
| Male sex | 0.703 | 0.354–1.394 | 0.313 |
| Age (years) | 1.034 | 1.009–1.060 | 0.007 |
| Body mass index (kg/m2) | 0.986 | 0.894–1.087 | 0.776 |
| Hypertension | 1.543 | 0.736–3.237 | 0.251 |
| Diabetes mellitus | 2.361 | 1.300–4.289 | 0.005 |
| Dyslipidemia | 1.545 | 0.825–2.893 | 0.174 |
| Chronic kidney disease | 1.135 | 0.415–3.102 | 0.806 |
| Diastolic blood pressure | 0.987 | 0.973–1.002 | 0.080 |
| Inotropic score | 1.002 | 0.992–1.011 | 0.720 |
| Ischemic cardiogenic shock | 1.151 | 0.462–2.867 | 0.763 |
| Peak CK-MB (ng/mL) | 1.001 | 1.000–1.002 | 0.008 |
| LV EF after ECMO insertion (%) | 0.965 | 0.943–0.988 | 0.003 |
| Shock-to-ECMO insertion time (min) | 1.000 | 1.000–1.001 | 0.127 |
| Use of IABP | 2.365 | 1.164–4.804 | 0.017 |
| Use of CRRT | 3.529 | 1.982–6.286 | < 0.001 |
| Use of mechanical ventilator | 1.462 | 0.534–4.006 | 0.460 |
| ECPR | 1.647 | 0.922–2.940 | 0.092 |
CK-MB creatine kinase-MB, LVEF left ventricular ejection fraction, ECMO extracorporeal membrane oxygenation, IABP intra-aortic balloon pump, CRRT continuous renal replacement therapy, ECPR extracorporeal cardiopulmonary resuscitation.